Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
Other Equity
Atara Biotherapeutics Inc
Other Equity Peer Comparison
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Other Equity
-$55k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other Equity
-$2.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-18%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Equity
$17.5B
|
CAGR 3-Years
672%
|
CAGR 5-Years
158%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Equity
-$190m
|
CAGR 3-Years
39%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Equity
-$23.9m
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Equity
-$77.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Atara Biotherapeutics Inc's Other Equity?
Other Equity
-55k
USD
Based on the financial report for Mar 31, 2024, Atara Biotherapeutics Inc's Other Equity amounts to -55k USD.
What is Atara Biotherapeutics Inc's Other Equity growth rate?
Other Equity CAGR 1Y
95%
Over the last year, the Other Equity growth was 95%.